[1] |
王臻,王显.冠心病经皮冠状动脉介入术后合并抑郁和(或)焦虑的中西医研究进展[J].世界中西医结合杂志,2016,11(2):292-296.
|
[2] |
Inokuchi R,Hara Y,Yasuda H,et al.Differences in characteristics and outcomes between community- and hospital-acquired acute kidney injury:A systematic review and meta-analysis[J].Clin Nephrol,2017,88(10):167-182.
|
[3] |
Ali-Hassan-Sayegh S,Mirhosseini SJ,Haddad F,et al.Protective effects of corticosteroids in coronary artery bypass graft surgery alone or combined with valvular surgery: an updated and comprehensive meta-analysis and systematic review[J].Interact Cardiovasc Thorac Surg,2015,20(6):825-836.
|
[4] |
李秀珍,谭晓,高逸冰,等.血清中性粒细胞明胶酶相关脂质运载蛋白对对比剂肾病的早期预测价值[J].中华老年多器官疾病杂志,2019,18(3): 210-213.
|
[5] |
McCullough PA.Contrast-Induced Nephropathy: Definitions,Epidemiology,and Implications[J].Interv Cardiol Clin,2014,3(3): 357-362.
|
[6] |
乔凤婕,周发展,杨申,等.远程缺血预处理预防对比剂肾病的研究进展[J/CD].中华临床医师杂志(电子版),2017,11(5):794-797.
|
[7] |
Yang JS,Peng YR,Tsai SC,et al.The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)[J].Biomedicine (Taipei),2018,8(1):1.
|
[8] |
Pflueger A,Abramowitz D,Calvin AD.Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus[J].Med Sci Monit,2009,15(6): RA125-RA136.
|
[9] |
Iyer RS,Schopp JG,Swanson JO,et al.Safety essentials: acute reactions to iodinated contrast media[J].Can Assoc Radiol J,2013,64(3):193-199.
|
[10] |
Araujo GN,Wainstein MV,McCabe JM,et al.Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention[J].J Interv Cardiol,2016,29(5):447-453.
|
[11] |
Abellás-Sequeiros RA,Raposeiras-Roubin S,Abu-Assi E,et al.Mehran contrast nephropathy risk score: Is it still useful 10 years later[J].J Cardiol,2016,67(3):262-267.
|
[12] |
Chou RH,Huang PH,Hsu CY,et al.CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions[J].J Formos Med Assoc,2016,115(7): 501-509.
|
[13] |
Wang Y,Zhao HW,Zhang XJ,et al.CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience[J].BMC Cardiovasc Disord,2019,19(1):74
|
[14] |
Zeng JF,Chen SQ,Ye JF,et al.A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes[J].Clin Exp Nephrol,2019,23(7):969-981.
|
[15] |
McMahon BA,Koyner JL,Murray PT.Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery:a critical review[J].Curr Opin Crit Care,2010,16(6): 550-555.
|
[16] |
Benzer M,Alpay H,Baykan Ö,et al.Serum NGAL,cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children[J].Ren Fail,2016,38(1):27-34.
|
[17] |
Liao B,Nian W,Xi A.Evaluation of a diagnostic test of serum neutrophil gelatinase-associated lipocalin (ngal) and urine kim-1 in contrast-induced nephropathy (CIN)[J].Med Sci Monit,2019,19:565-570.
|
[18] |
孙曼丽,韩卫星.叶酸、同型半胱氨酸与动脉粥样硬化关系的研究进展[J].医学综述,2017,23(2):223-226.
|
[19] |
崔雪林,马自东,陈倩,等.血清同型半胱氨酸、胱抑素C水平对冠脉介入术后对比剂肾病预测价值分析[J].中国医药科学,2019,9(5):245-247.
|
[20] |
Zhou FZ,Song W,Yin LH,et al.Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome[J].Eur Rev Med Pharmacol Sci,2017,21(20):4642-4648.
|
[21] |
Windgassen EB,Funtowicz L,Lunsford TN,et al.C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians[J].Postgrad Med,2011,123(1):114-119.
|
[22] |
Gu G,Yuan X,Zhou Y,et al.Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention[J].BMC Cardiovasc Disord,2019,19(1):152.
|
[23] |
Goussot S,Mousson C,Guenancia C,et al.N-terminal fragment of pro B-type natriuretic peptide as a marker of contrast-induced nephropathy after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J].Am J Cardiol,2015,116(6):865-871.
|
[24] |
Lin KY,Wu ZY,You ZB,et al.Pre-procedural n-terminal pro-b type natriuretic peptide predicts contrast-induced acute kidney injury and long-term outcome in elderly patients after elective percutaneous coronary intervention[J].Int Heart J,2018,59(5):926-934.
|
[25] |
Chaykovska L,Heunisch F,von Einem G,et al.Urinary vitamin D binding protein and KIM-1 are potent new biomarkers of major adverse renal events in patients undergoing coronary angiography[J].Plos One,2016,11(1):e145723.
|
[26] |
Lou B,Gao H.Contrast-induced nephropathy prevention by remote ischemic preconditioning: Effect of diabetes mellitus[J].Int J Cardiol,2018,268:41.
|
[27] |
Oda E,Kawai R,Aizawa Y.Lymphocyte count was significantly associated with hyper-LDL cholesterolemia independently of high-sensitivity C-reactive protein in apparently healthy Japanese[J].Heart Vessels,2012,27(4):377-383.
|
[28] |
李顺宝,苑国富,于兵,等.NLR和hs-CRP在NSTEMI患者行冠状动脉介入术后造影剂肾病的预测价值[J].河北医药,2015,37(7): 985-988.
|
[29] |
Zhao K,Li Y,Gao S.Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting[J].Coron Artery Dis,2015,26(3):220-224.
|
[30] |
Liu T,Shao Q,Miao S,et al.Red cell distribution width as a novel,inexpensive marker for paroxysmal atrial fibrillation[J].Int J Cardiol,2014,171(2):e52-e53.
|
[31] |
Kurtul A,Yarlioglues M,Murat SN,et al.Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome[J].Angiology,2015,66(5):433-440.
|
[32] |
Zbierska-Rubinkiewicz K,Trebacz O,Tomala M,et al.Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction[J].Folia Med Cracov,2017,57(3): 87-99.
|